sabervel
pharmathen s.a. - irbesartan - hypertension - agents acting on the renin-angiotensin system - sabervel is indicated in adults for the treatment of essential hypertension.it is also indicated for the treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen.
irbesartan mylan 75 mg filmtabletten
irbesartan amarox 75 mg filmtabletten
co-aprovel 300mg + 25mg tablet, film coated
sanofi-aventis phils inc - irbesartan , hydrochlorothiazide - tablet, film coated - 300mg + 25mg
co-aprovel 150mg/ 12.5mg film-coated tablet
sanofi-aventis philippines, inc. - irbesartan/hydrochlorothiazide - film-coated tablet - 150mg/ 12.5mg
co-aprovel 300mg/ 12.5mg film-coated tablet
sanofi-aventis philippines, inc. - irbesartan , hydrochlorothiazide - film-coated tablet - 300mg/ 12.5mg
co-aprovel 300 mg / 25 mg film-coated tablet
sanofi-aventis philippines, inc.; distributor: sanofi-aventis philippines, inc. - irbesartan / hydrochlorothiazide - film-coated tablet - 300 mg / 25 mg
co-aprovel 300/12.5 tablet
synovia pharma plc. - hydrochlorothiazide + irbesartan - tablet - 12.5 mg + 300 mg
co-aprovel 150 mg, 12.5 mg
شركة ألفه للأدوية - ulfa pharma co. - irbesartan 150 mg, hydrochlorothiazide 12.5 mg - 150 mg, 12.5 mg
co-aprovel 300 mg, 25 mg
شركة ألفه للأدوية - ulfa pharma co. - irbesartan 300 mg, hydrochlorothiazide 25 mg - 300 mg, 25 mg